An analyst takes over a purity method written years ago for a ten-residue peptide: a C18 column with 100 angstrom pores, a water and acetonitrile gradient, trifluoroacetic acid in both solvents. Asked to run a new sample, a peptide of about forty residues, the analyst loads it onto the same column and gets a tidy main peak and a high area percentage. The trace looks fine. The question nobody asked is whether everything in the vial actually made it through the column in a form the detector could see.
Column choice is one of the least discussed variables in peptide purity work, partly because most published results are generated on C18 and the column line on a report is easy to skim past. This article explains what the main column variables do and how they change a result.
Three decisions hidden in one column description
A column label such as “C18, 4.6 x 150 mm, 3.5 µm, 100 A” bundles several separate choices. For peptide separations the three that matter most are:
- Pore size, which decides whether a molecule can reach most of the retentive surface.
- Bonded ligand, which sets how strongly and by what mechanism the surface holds the molecule.
- Mobile-phase additive, not part of the column itself but inseparable from how the column behaves with peptides.
Dimensions and particle size affect efficiency and pressure, but they rarely change which species can be seen at all. The three above can.
Pore size: access comes before chemistry
Porous silica particles carry nearly all of their surface area inside the pores rather than on the outside of the particle. A molecule that fits into the pores meets that surface; one that does not fit interacts only with the small exterior. The consequences of exclusion are weak retention, broad peaks and unpredictable yield from the column.
The usual working convention is that pores around 100 angstroms suit small molecules and short peptides, while wide-pore packings around 300 angstroms are used for larger peptides and proteins. The failure mode on the narrow-pore side is subtle. The species most likely to be excluded are the biggest in the sample, such as aggregates and larger synthesis byproducts. Those are precisely the impurities a purity method should reveal. If they pass poorly or not at all, the main peak looks cleaner than the material is.
Bonded ligand: how firmly the surface holds
The number after the C is the length of the alkyl chain bonded to the silica. Longer chains give a more hydrophobic surface and stronger retention. A phenyl ligand works differently.
| Ligand | Retention character | When analysts reach for it |
|---|---|---|
| C18 | Strongest hydrophobic retention | Default for short and medium-length peptides |
| C8 | Intermediate | Larger or more hydrophobic sequences that give broad peaks or poor yield on C18 |
| C4 | Weakest | Long peptides and proteins that would otherwise be held too tightly |
| Phenyl | Hydrophobic plus aromatic (pi-pi) interaction | A second, different selectivity to test whether one peak hides two species |
Two opposite problems sit on either side of the C18 default. A very short, very polar peptide may barely retain on C18 and elute near the solvent front, where resolution from other early material is poor. A large hydrophobic peptide may bind so strongly that only a steep, high-organic gradient releases it, and any fraction that never elutes simply vanishes from the calculation. In both cases the area percentage reports on what the detector saw, not on what was in the vial.
The additive: peak shape against detection
Water and acetonitrile carry the separation, but the acidic modifier strongly shapes peptide chromatography. Trifluoroacetic acid pairs with basic residues and produces sharp, symmetric peaks, which is why it dominates UV purity methods. Its drawback is severe signal suppression in electrospray mass spectrometry. When the column is connected to a mass spectrometer, formic acid is the common substitute: peaks broaden somewhat, but ionization improves considerably. A method optimized for one detector is often a compromise for the other.
The acid used during purification also affects the counter-ion carried by the final solid, a separate issue that matters when reconciling mass or weight figures. See TFA versus acetate counter-ions.
Checking whether a column is right for the molecule
An analyst developing or reviewing a peptide method can ask a short set of questions:
- Is the pore size appropriate for the length of the peptide and its likely aggregates?
- Does the main peak elute well clear of the void, with room for early impurities to resolve?
- Does the gradient finish with enough organic strength, and a wash step, to elute strongly retained material?
- Has an orthogonal separation, such as a phenyl column or a different pH, been tried to see whether the main peak splits?
- Was the method written for this molecule, or borrowed from another one?
The last question is often the most revealing. A generic method can produce a respectable-looking chromatogram for nearly anything, which is exactly why it can mislead. The broader principles of the technique are in reverse-phase HPLC for peptide purity.
Why two laboratories can both be right
Because column chemistry changes retention, resolution and what elutes at all, two competent laboratories testing the same material on different columns can report different purity figures without either being in error. Differences in gradient, additive and integration add to this. When figures disagree, the column line is one of the first places to compare, as discussed in why suppliers report different peptide purity. Battle Born publishes an independent reverse-phase HPLC result for each product; on any such report, the method details are what make that kind of comparison possible.
Questions
Is C18 wrong for peptides?
No. It is the right starting point for most short and medium peptides. It becomes a poor choice for very polar sequences that barely retain and for large hydrophobic ones that bind too strongly.
What does wide-pore mean?
Packings with pores around 300 angstroms, large enough for bigger peptides and proteins to reach the internal bonded surface.
Why use a phenyl column as a second method?
Its retention depends partly on aromatic interaction, so its selectivity differs from C18. A peak that stays single on both is better evidence of a single species.
Does a high purity figure prove the column was suitable?
No. Material that never elutes, or that elutes in the void, is not counted. A suitable method has to be shown to retain and release the sample properly.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.